INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$4,830
1,014 sh
Apr 13, 2026Apr 14, 2026
Page 970 of 1737
← PrevNext →
traded Apr 13, 2026
+1d
SEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
PP
Patak Stephen PaulChief Revenue Officer
BZAIBlaize Holdings, Inc.
Option exercise
M—
2,500 sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

13
MR
Moll Laurent RChief Operating Officer
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,003 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$16K
3,400 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

13
CA
Cortina Ignacio ADirector
LNTALLIANT ENERGY CORP
Grant or award
A$49K
667 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
DA
D'Adamio AnthonySVP & General Counsel
BVSBioventus Inc.
Option exercise
M—
9,925 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

13
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M—
1,500 sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

13
HD
Hallinan Patrick DEVP, CFO & Chief Admin Officer
SWKSTANLEY BLACK & DECKER, INC.
Option exercise
M—
3,852 sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

12
KD
Kohler DonaldCEO, PVH Americas
PVHPVH CORP. /DE/
Tax withholding
F$57K
630 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
HP
Hung PriscillaDirector
VEEVVEEVA SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$115K
750 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$387K
8,973 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
TM
Testa Daniel M.Director
FVCBFVCBankcorp, Inc.
Option exercise
M$198K
21.5K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Tax withholding
F$103K
1,389 sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

12
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$252K
5,927 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
SL
Singleton Mark LeonardSVP & CFO
BVSBioventus Inc.
Tax withholding
F$51K
5,648 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
SD
Savman DavidGlobal Brand President, CK
PVHPVH CORP. /DE/
Tax withholding
F$57K
630 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
SA
Subrahmanyam AmbaChief People Officer
PVHPVH CORP. /DE/
Tax withholding
F$91K
1,000 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
FJ
Falotico Nancy JoyDirector
LNTALLIANT ENERGY CORP
Grant or award
A$57K
778 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

12
GR
Goldman Lea RytzGlobal Brand President, TH
PVHPVH CORP. /DE/
Tax withholding
F$77K
846 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.07M
1,860 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

11
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Tax withholding
F$9,626
1,680 sh
Apr 8, 2026Apr 14, 2026
traded Apr 8, 2026
+6dSEC Form 4

Evidence

10
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Grant or award
A—
1.00M sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

10
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$19K
2,693 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

10
CF
Courtemanche Craig F. Jr.Director, Chairman of the Board
PCORPROCORE TECHNOLOGIES, INC.
Option exercise · 10b5-1 plan
M$136K
56.1K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
ND
Natan DavidDirector
SBFMSunshine Biopharma Inc.
Grant or award
A—
100.0K sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

9
WT
Williams TimothyEVP and Chief Legal Officer
GERNGERON CORP
Grant or award
A—
2.50M sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

9
CB
Clark Christopher BDirector
OTTROtter Tail Corp
Grant or award
A—
1,900 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

9
SP
Sheikh Khurram PDirector, Chief Executive Officer
CXAICXApp Inc.
Grant or award
A—
675.0K sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

9
MJ
McKeehan JenniferDirector
REALTheRealReal, Inc.
Grant or award
A—
4,247 sh
Apr 13, 2026Apr 14, 2026
traded Apr 13, 2026
+1dSEC Form 4

Evidence

9
HD
Hallinan Patrick DEVP, CFO & Chief Admin Officer
SWKSTANLEY BLACK & DECKER, INC.
Option exercise
M—
3,852 sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

9
AE
Allison EricChief Product Officer
JOBYJoby Aviation, Inc.
Option exercise
M—
53.5K sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

9
SL
Solimene LewisCFO and CIO
MRCCMONROE CAPITAL Corp
Disposition to issuer
D—
981 sh
Apr 14, 2026Apr 14, 2026
traded Apr 14, 2026
+0dSEC Form 4

Evidence

9
SL
Singleton Mark LeonardSVP & CFO
BVSBioventus Inc.
Option exercise
M—
13.0K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
SD
Semler DakotaDirector, Chief Executive Officer
XOSXos, Inc.
Tax withholding
F$26K
14.5K sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
YD
Yellin Jonathan DEVP AND GENERAL COUNSEL
CRAICRA INTERNATIONAL, INC.
Tax withholding
F$26K
158 sh
Apr 11, 2026Apr 14, 2026
traded Apr 11, 2026
+3dSEC Form 4

Evidence

9
LA
Lufkin Paul AndrewSenior Vice President, Sales
BYNDBEYOND MEAT, INC.
Tax withholding
F$660
1,107 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
SC
Sedor ChristianChief Accounting Officer
ARHSArhaus, Inc.
Tax withholding
F$1,794
265 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence

9
GJ
Gibbs JonathanCDCO (See Remarks)
RIOTRiot Platforms, Inc.
Disposition to issuer
D—
1.15M sh
Apr 12, 2026Apr 14, 2026
traded Apr 12, 2026
+2dSEC Form 4

Evidence

9
SA
Subrahmanyam AmbaChief People Officer
PVHPVH CORP. /DE/
Tax withholding
F$46K
505 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC Form 4

Evidence